Financing channel feed – Endpoints News

Financing channel feed

Insmed aims to raise $750M in one of the largest stock offerings this year

2 days ago

Exclusive: Commons Clinic raises $26M Series B to offer preventive testing

3 days ago

Gene therapy biotech SpliceBio gets $135M shortly after starting first clinical trial

4 days ago

Exclusive: Scorpion spinout gets $177M for stealthy pipeline amid China competition

5 days ago

Odyssey pulls back from IPO plans as public markets remain frozen

5 days ago

Updated: Omada Health rose 21% in its public market debut

Last week

At a crossroads, biotechs are passing on reverse mergers in 2025

Last week

Omada Health is going public at a $1.1B valuation

Last week

Exclusive: Allay reaches $57.5M Series D milestone for post-surgical pain drug

Last week

Exclusive: Tech VC Amplify raises $200M for first biotech fund, hires Elliot Hershberg as new partner

Last week

Exclusive: CinDome gets another $40M to advance gastroparesis drug

Last week

Canid raises $10M to manage vaccines for pediatricians

Last week

Korean startup Curogen seeks global expansion, new funding to back autoimmune drugs

Last week

As a challenging first half nears a close, biopharma uncertainty persists

3 weeks ago

Exclusive: Movement disorder biotech Vima steps onto scene with $60M

3 weeks ago

Post-Hoc Live: Is biotech sentiment really as bad as it seems?

3 weeks ago

Updated: MD Anderson-allied investment firm targets $250M for second cancer biotech fund

3 weeks ago

Brooklyn Health raises $6.5M to standardize mental health assessment

3 weeks ago

Investors pump $130M into protein degrader startup GlycoEra

3 weeks ago

Syndeio debuts with $90M+ to bring together synapse repair drugs

3 weeks ago

Exclusive: Toronto biotech ProteinQure nears the clinic with peptide platform as it raises $11M Series A

3 weeks ago

Updated: Hinge Health jumped 18% on its first day as the digital health IPO market reawakens

4 weeks ago

Hinge Health is going public on Thursday at a $3B valuation

4 weeks ago

Reproductive health biotech snags $65M to develop former Novartis and Merck KGaA drugs

4 weeks ago

12 3 4 Next page Last page